Bad science

6 January 2009 By John Foley

It s no shock that the chemicals firm has buckled under $26bn of debt it can no longer service. That s what happens to overleveraged cyclical companies in a downturn. But the speed and intensity of Lyondell’s meltdown bodes ill for other troubled deals.

This content is for Subscribers only

To access full Breakingviews.com content you must be a subscriber. Please use the following link to request a trial.

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)